06 Pass through pratfalls - a podcast by Darrell White
from 2018-06-27T21:59:29
::
::
In this episode, Darrell White, MD, discusses Omidria and how and why it’s used in cataract surgery. He also shares his thoughts on the pass-through status of this product and others and where things are headed.
- Disclaimer :09
- Introduction :20
- Financial disclosures :50
- What is Omidria, how is it used, and why is it controversial? 1:40
- Along came floppy iris syndrome 2:10
- The difficulty in predicting when IFIS will occur 5:09
- The importance of pupil size in cataract surgery 7:59
- Why people are not using Omidria 10:50
- What makes Omidria controversial 12:50
- Background on the pass-through regulation 13:22
- How the price is set and how it is paid for 14:13
- A 3-year deadline and use it or lose it funds 18:10
- What happens when passthrough ends 20:26
- What happened in December 2017? 24:41
- The pass-through extension 26:30
- Mass confusion over when the 2-year period begins 27:41
- Omeros is not the bad actor here 29:47
- Congress hasn’t done its job 30:33
- A decision needs to be made one way or the other 32:13
- And about mitomycin C 33:56
Further episodes of Eye Care Out Loud
Further podcasts by Darrell White
Website of Darrell White